KLRK1 and ovarian cancer: NK specific CAR-NK cells, especially the optimized NKG2D-2B4 ζ- IPSC NK cells, significantly enhanced the killing ability, significantly inhibited tumor growth and prolonged survival time in ovarian cancer xenotransplantation models.